Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: no GLP compliance, no study period.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium peroxodisulphate
EC Number:
231-892-1
EC Name:
Disodium peroxodisulphate
Cas Number:
7775-27-1
Molecular formula:
Na2S2O8
IUPAC Name:
disodium peroxodisulphate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: own breed
- Age at study initiation: male: 52 days; female: 70 days
- Weight at study initiation: 165 to 185 g
- Housing: individually in Makrolon cages
- Diet (e.g. ad libitum): Altromin
- Water (e.g. ad libitum): tap water, ad libitum


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 0.5 °C
- Humidity (%): 55 ± 5 %:
- Photoperiod (hrs dark / hrs light): 12 hours light/ 12 hours dark

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: Hydroxypropyl-Methylcellulose E 4 M
Details on oral exposure:
Disodium peroxodisulfate was dissolved in 0.8 % aqueous Hydroxypropyl-Methylcellulose E 4 M and applied per gavage in a constant volume of 10 mL/kg bw.
Doses:
215, 464, 562, 681, 825, 1000, 1210, 1470 mg/kg p.o.
No. of animals per sex per dose:
10
Control animals:
no
Details on study design:
- Duration of observation period following administration: 4 weeks
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, mortalities
Statistics:
According to Litchfield and Wilcoxon.

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LD50
Effect level:
1 200 mg/kg bw
Remarks on result:
other: 24 h
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
930 mg/kg bw
Remarks on result:
other: 14 d
Sex:
female
Dose descriptor:
LD50
Effect level:
1 000 mg/kg bw
Remarks on result:
other: 24 h
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
920 mg/kg bw
Remarks on result:
other: 14 d
Sex:
male
Dose descriptor:
LD0
Effect level:
464 mg/kg bw
Remarks on result:
other: 14 d
Sex:
female
Dose descriptor:
LD0
Effect level:
562 mg/kg bw
Remarks on result:
other: 14 d
Mortality:
See table below at Sect. "Any other information on results"
Clinical signs:
other: Sedation, ataxia, dyspnoea (464 mg/kg), diarrhoea, muscular hypotension, mydriasis (562 mg/kg), reduced feed intake, face-down position (681 mg/kg)
Gross pathology:
Dead animals: liver- and kidney-parenchyma pale, partly sabulous surface structure, distinct haemorrhage and ulceration on gastric wall and intestinal wall, gastric wall and intestinal wall thin-walled, liver tissue green-brown coloured.
surviving animals: without specific pathologic findings; 2 animals liver surface gross structured
Other findings:
no data

Any other information on results incl. tables

Mortality:

Dose [mg/kg p.o.]

24 h

14 d

 

Male

Female

Male

Female

215

0

0

0

0

464

0

0

0

0

562

0

0

0

0

681

0

0

1

1

852

3

2

5

5

1000

1

5

2

7

1210

5

7

9

7

1470

7

9

10

10

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
LD50-values of 930 mg/kg bw (males) and 920 mg/kg bw (females) were determined after a 14 days observation period. Corresponding LD0 values of 464 mg/kg in male rats and 562 mg/kg in female rats were revealed. Based on the obtained results disodium persulfate was classified and labelled as toxic cat. 4 H302 (harmful if swallowed) according to Regulation 1272/2008/EC (CLP).
Executive summary:

Disodium persulfate was tested for toxicity by oral application in male and female Sprague Dawley rats. No guideline was specified. Ten male and ten female Sprague-Dawley rats per group were dosed with 215, 464, 562, 681, 825, 1000, 1210 and 1470 mg/kg bw disodium persulfate and were observed for 4 weeks. Clinical signs and mortalities were recorded. All animals were subjected to gross autopsy after termination of the study. No animal died in the lowest dose group (215 mg/kg bw), two rats (one male and one female rat) died in the intermediate dose group (681 mg/kg bw) and all rats died in the highest dose group (1470 mg/kg bw). Death occurred within 60 minutes until 6 days after application. Surviving animals had recovered after 48 hours after application. Clinical signs included sedation, dyspnoea, diarrhoea, muscular hypotension, reduced feed intake and face-down position. LD50-values of 930 mg/kg bw (males) and 920 mg/kg bw (females) were determined after a 14 days observation period and corresponding LD0 values of 464 mg/kg in male rats and 562 mg/kg in female rats were revealed.